Rebecca Li is Chief Executive Officer of Vivli, a center for global clinical research data, where she leads the AMR Register effort. She is also on the faculty at the Center for Bioethics at the Harvard Medical School, USA.
Before her current role, she was the Executive Director of the MRCT Center of Brigham and Women’s Hospital and Harvard for over 5 years and remains a Senior Advisor at the Center. She has over 25 years of experience spanning the entire drug development process, including experience in biotech, pharma, and contract research organizations (CROs). She completed a postdoctoral fellowship in 2013 in the Division of Medical Ethics at Harvard Medical School. Rebecca received her PhD in Chemical and Biomolecular Engineering from Johns Hopkins University, USA.